MARKET

LGNDZ

LGNDZ

Ligand Pharma
OTCPK
0.0055
0.0000
0.00%
Closed 13:40 12/04 EST
OPEN
0.0055
PREV CLOSE
0.0055
HIGH
0.0055
LOW
0.0055
VOLUME
2.20K
TURNOVER
12
52 WEEK HIGH
0.013
52 WEEK LOW
0.0006
MARKET CAP
--
P/E (TTM)
0.0026
1D
5D
1M
3M
1Y
5Y
1D
Ligand Pharmaceuticals Incorporated - Equity Right (LGNDZ) Price Target Increased by 47.34% to 0.01
NASDAQ · 11/09 04:59
Weekly Report: what happened at LGNDZ last week (0908-0912)?
Weekly Report · 09/15 11:56
Weekly Report: what happened at LGNDZ last week (0901-0905)?
Weekly Report · 09/08 11:58
Weekly Report: what happened at LGNDZ last week (0825-0829)?
Weekly Report · 09/01 11:52
Weekly Report: what happened at LGNDZ last week (0818-0822)?
Weekly Report · 08/25 12:06
Weekly Report: what happened at LGNDZ last week (0811-0815)?
Weekly Report · 08/18 11:56
Weekly Report: what happened at LGNDZ last week (0804-0808)?
Weekly Report · 08/11 12:06
Ligand raises 2025 revenue and EPS guidance to $225M and $7 amid royalty portfolio momentum
Seeking Alpha · 08/08 00:02
More
About LGNDZ
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including OTCPK: LGNDZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGNDZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGNDZ stock methods without spending real money on the virtual paper trading platform.